GS, P., JW, N., JS, L., & KK, L. (2026). Cost-Effectiveness of Vascular Endothelial Growth Factor Inhibitors in the Management of Wet Age-Related Macular Degeneration: A Systematic Review. Value in health regional issues, 53, 101542. https://doi.org/10.1016/j.vhri.2025.101542
Chicago Style (17th ed.) CitationGS, Paneerselvam, Ng JW, Lim JS, and Lee KK. "Cost-Effectiveness of Vascular Endothelial Growth Factor Inhibitors in the Management of Wet Age-Related Macular Degeneration: A Systematic Review." Value in Health Regional Issues 53 (2026): 101542. https://doi.org/10.1016/j.vhri.2025.101542.
MLA (9th ed.) CitationGS, Paneerselvam, et al. "Cost-Effectiveness of Vascular Endothelial Growth Factor Inhibitors in the Management of Wet Age-Related Macular Degeneration: A Systematic Review." Value in Health Regional Issues, vol. 53, 2026, p. 101542, https://doi.org/10.1016/j.vhri.2025.101542.